NEW YORK (360Dx) – A consortium of researchers is developing an automated, low-cost point-of-care test for the molecular diagnosis of aggressive lymphoma that it anticipates will enter field testing later this year in Botswana.
NEW YORK (360Dx) – A consortium of researchers is developing an automated, low-cost point-of-care test for the molecular diagnosis of aggressive lymphoma that it anticipates will enter field testing later this year in Botswana.
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.